Top Gap Ups and Downs on Monday: NOW, INTC, EQNR and More
Gaps can show signals that something important has happened to the fundamental or the psychology of traders that accompanies this market movement.
Study Finds Patients Lost More Weight on Mounjaro Than Ozempic
Novo Nordisk (NVO) Outpaces Stock Market Gains: What You Should Know
Will NVO (Novo Nordisk) Provide Any Buying Opportunity?
Novo Nordisk A/S (NVO), a healthcare company engages in the research, development, manufacture & marketing of the pharmaceutical products worldwide.
'Zepbound Sheds More Weight Than Wegovy, Study Finds' - Forbes
Eli Lilly's popular obesity injection Zepbound trounces Novo Nordisk's Wegovy when it comes to shedding weight, according to new research published Monday, intensifying competition between the two pha
Novo Nordisk A/S - Share Repurchase Programme
Lilly and Novo Owner Back UK Biotech Myricx in £90 Million Round
British biotech spinout Myricx Pharma Ltd has raised £90 million ($115 million) from investors including the controlling shareholder of Ozempic maker Novo Nordisk A/S to fund the development of its cancer drugs.
EXCLUSIVE: GLP-1 Weight-Loss Drugs Could Become A Trillion-Dollar Market, Predicts Tema ETFs CEO
The GLP-1 drug market for obesity treatment is expected to skyrocket to $1 trillion or more, according to Maurits Pot, founder and CEO of Tema ETFs, who shared this optimistic forecast in an exclusive interview with Benzinga.
Small, Mid-size Biotechs Could See M&A Action in H2 - PwC
The Trader: Conagra Took a GLP-1 Hit. Why Its Stock Is Worth a Look. -- Barron's
By Paul R. La Monica Ozempic and other popular injectable GLP-1 drugs aren't just helping dieters shed pounds. They're also leading to share price losses for top food stocks. Take a look at Conagra B
Overnight News: US stocks closed higher. The growth rate of US non-farm employment and wages both slowed down. The Federal Reserve released its semi-annual monetary policy report. Nvidia's rating was downgraded, which is rare.
For more global financial news, please visit 24/7 real-time financial news. Market closing: Non-farm data strengthens rate cut expectations. Nasdaq and S&P hit record highs again. Top 20 US stock trading volume on July 5: Tesla rose for the eighth consecutive day, with an increase of more than 27% this week. US WTI crude oil fell 0.86% on Friday, rising 2% this week. Popular China concept stocks did not rise or fall on Friday, with TSMC rising 0.8% and Chinese electric vehicle stocks falling overall. European stocks closed generally lower, with the Euro Stoxx 50 index down 0.19%. Macro: Major Democratic donors further pressure - more than 100 wealthy businessmen jointly wrote to ask Biden to withdraw. Biden's trust.
Novo Nordisk's (NYSE:NVO) Ozempic Linked to Lower Risk of Cancer
Study Links GLP-1 Drugs, Metformin to Lower Risk of Certain Cancers
Express News | Shares of Lilly and Novo Nordisk Are Trading Higher Following a Study Showing Patients Taking GLP-1 Treatments Have a Reduced Risk of Developing Obesity-related Cancers
GLP-1 Treatments Such As Wegvoy, Mounjaro Cut Obesity-Related Cancer Risks, Study Finds
In a study published in JAMA Network, patients with type 2 diabetes taking GLP-1 treatments have a reduced risk of developing ten types of obesity-related cancers compared to those on insulin and othe
Novo Nordisk's stock price continues to rise, investors are not worried about the Harvard "Eye Disease Report".
The stock price of Novo Nordisk seems unaffected by Harvard's "eye disease" report. Earlier, on Wednesday local time, a study by Harvard-affiliated hospitals found that the risk of developing a rare eye disease called non-arteritic anterior ischemic optic neuropathy (NAION) may increase when patients take Novo Nordisk's weight loss drugs Ozempic and Wegovy. This eye disease can lead to loss of vision in one eye. The news dragged down Novo Nordisk's stock price by 4.8% at one point on Wednesday, but ultimately the stock price seemed to withstand the impact of the report, and on Friday, Novo Nordisk maintained its upward trend with a gain of more than 2.2% during the trading day. The study analyzed data from 2017.
UK Pharmaceutical Trade Group Slams Novartis, Three Others for Breaches
The Association of the British Pharmaceutical Industry's Prescription Medicines Code of Practice Authority flagged four major pharmaceutical companies for breaching its regulations. The British trade
European Equities Traded in the US as American Depositary Receipts Rise in Friday Trading
European equities traded in the US as American depositary receipts were higher late Friday morning, rising 0.53% to 1,446.18 on the S&P Europe Select ADR Index. From continental Europe, the gainers we
Express News | 'Ozempic May Lower Risk of Obesity-Related Cancers, Study Finds' - Bloomberg Law
Novo Nordisk Reprimanded in UK for Failure to Disclose Payments to Healthcare Sector